GO FUND IT NOW

WEILL MEDICAL COLL OF CORNELL UNIV

Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles

Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles is a funding opportunity from WEILL MEDICAL COLL OF CORNELL UNIV, up to 317911, closing November 30, 2026.

Funder
WEILL MEDICAL COLL OF CORNELL UNIV
Funding
317911
Deadline
Nov 30, 2026
(122d left)

Overview

Project Summary: High-risk prostate cancer (PC) is the second most common cause of cancer-related death in men. Improvements in overall survival and long-term morbidity will depend on the ability of the operating surgeon to completely resect regional metastatic lymph nodes (LNs) and obtain negative surgical margins;…

Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles | Go Fund It Now